BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 29322246)

  • 1. De novo variants in SETD1B are associated with intellectual disability, epilepsy and autism.
    Hiraide T; Nakashima M; Yamoto K; Fukuda T; Kato M; Ikeda H; Sugie Y; Aoto K; Kaname T; Nakabayashi K; Ogata T; Matsumoto N; Saitsu H
    Hum Genet; 2018 Jan; 137(1):95-104. PubMed ID: 29322246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An atypical 12q24.31 microdeletion implicates six genes including a histone demethylase KDM2B and a histone methyltransferase SETD1B in syndromic intellectual disability.
    Labonne JD; Lee KH; Iwase S; Kong IK; Diamond MP; Layman LC; Kim CH; Kim HG
    Hum Genet; 2016 Jul; 135(7):757-71. PubMed ID: 27106595
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Roston A; Evans D; Gill H; McKinnon M; Isidor B; Cogné B; Mwenifumbo J; van Karnebeek C; An J; Jones SJM; Farrer M; Demos M; Connolly M; Gibson WT; ;
    J Med Genet; 2021 Mar; 58(3):196-204. PubMed ID: 32546566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel de novo frameshift variant in SETD1B causes epilepsy.
    Den K; Kato M; Yamaguchi T; Miyatake S; Takata A; Mizuguchi T; Miyake N; Mitsuhashi S; Matsumoto N
    J Hum Genet; 2019 Aug; 64(8):821-827. PubMed ID: 31110234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruption of PHF21A causes syndromic intellectual disability with craniofacial anomalies, epilepsy, hypotonia, and neurobehavioral problems including autism.
    Kim HG; Rosenfeld JA; Scott DA; Bénédicte G; Labonne JD; Brown J; McGuire M; Mahida S; Naidu S; Gutierrez J; Lesca G; des Portes V; Bruel AL; Sorlin A; Xia F; Capri Y; Muller E; McKnight D; Torti E; Rüschendorf F; Hummel O; Islam Z; Kolatkar PR; Layman LC; Ryu D; Kong IK; Madan-Khetarpal S; Kim CH
    Mol Autism; 2019; 10():35. PubMed ID: 31649809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A genome-wide DNA methylation signature for SETD1B-related syndrome.
    Krzyzewska IM; Maas SM; Henneman P; Lip KVD; Venema A; Baranano K; Chassevent A; Aref-Eshghi E; van Essen AJ; Fukuda T; Ikeda H; Jacquemont M; Kim HG; Labalme A; Lewis SME; Lesca G; Madrigal I; Mahida S; Matsumoto N; Rabionet R; Rajcan-Separovic E; Qiao Y; Sadikovic B; Saitsu H; Sweetser DA; Alders M; Mannens MMAM
    Clin Epigenetics; 2019 Nov; 11(1):156. PubMed ID: 31685013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De novo missense variants in MEIS2 recapitulate the microdeletion phenotype of cardiac and palate abnormalities, developmental delay, intellectual disability and dysmorphic features.
    Douglas G; Cho MT; Telegrafi A; Winter S; Carmichael J; Zackai EH; Deardorff MA; Harr M; Williams L; Psychogios A; Erwin AL; Grebe T; Retterer K; Juusola J
    Am J Med Genet A; 2018 Sep; 176(9):1845-1851. PubMed ID: 30055086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microdeletion of 12q24.31: report of a girl with intellectual disability, stereotypies, seizures and facial dysmorphisms.
    Palumbo O; Palumbo P; Delvecchio M; Palladino T; Stallone R; Crisetti M; Zelante L; Carella M
    Am J Med Genet A; 2015 Feb; 167A(2):438-44. PubMed ID: 25428890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delineating the molecular and phenotypic spectrum of the SETD1B-related syndrome.
    Weerts MJA; Lanko K; Guzmán-Vega FJ; Jackson A; Ramakrishnan R; Cardona-Londoño KJ; Peña-Guerra KA; van Bever Y; van Paassen BW; Kievit A; van Slegtenhorst M; Allen NM; Kehoe CM; Robinson HK; Pang L; Banu SH; Zaman M; Efthymiou S; Houlden H; Järvelä I; Lauronen L; Määttä T; Schrauwen I; Leal SM; Ruivenkamp CAL; Barge-Schaapveld DQCM; Peeters-Scholte CMPCD; Galehdari H; Mazaheri N; Sisodiya SM; Harrison V; Sun A; Thies J; Pedroza LA; Lara-Taranchenko Y; Chinn IK; Lupski JR; Garza-Flores A; McGlothlin J; Yang L; Huang S; Wang X; Jewett T; Rosso G; Lin X; Mohammed S; Merritt JL; Mirzaa GM; Timms AE; Scheck J; Elting MW; Polstra AM; Schenck L; Ruzhnikov MRZ; Vetro A; Montomoli M; Guerrini R; Koboldt DC; Mosher TM; Pastore MT; McBride KL; Peng J; Pan Z; Willemsen M; Koning S; Turnpenny PD; de Vries BBA; Gilissen C; Pfundt R; Lees M; Braddock SR; Klemp KC; Vansenne F; van Gijn ME; Quindipan C; Deardorff MA; Hamm JA; Putnam AM; Baud R; Walsh L; Lynch SA; Baptista J; Person RE; Monaghan KG; Crunk A; Keller-Ramey J; Reich A; Elloumi HZ; Alders M; Kerkhof J; McConkey H; Haghshenas S; ; Maroofian R; Sadikovic B; Banka S; Arold ST; Barakat TS
    Genet Med; 2021 Nov; 23(11):2122-2137. PubMed ID: 34345025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel Kleefstra Syndrome-associated Variant That Affects the Conserved TPL
    Blackburn PR; Tischer A; Zimmermann MT; Kemppainen JL; Sastry S; Knight Johnson AE; Cousin MA; Boczek NJ; Oliver G; Misra VK; Gavrilova RH; Lomberk G; Auton M; Urrutia R; Klee EW
    J Biol Chem; 2017 Mar; 292(9):3866-3876. PubMed ID: 28057753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted next generation sequencing of a panel of autism-related genes identifies an EHMT1 mutation in a Kleefstra syndrome patient with autism and normal intellectual performance.
    Bock I; Németh K; Pentelényi K; Balicza P; Balázs A; Molnár MJ; Román V; Nagy J; Lévay G; Kobolák J; Dinnyés A
    Gene; 2016 Dec; 595(2):131-141. PubMed ID: 27651234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent reciprocal 16p11.2 rearrangements associated with global developmental delay, behavioural problems, dysmorphism, epilepsy, and abnormal head size.
    Shinawi M; Liu P; Kang SH; Shen J; Belmont JW; Scott DA; Probst FJ; Craigen WJ; Graham BH; Pursley A; Clark G; Lee J; Proud M; Stocco A; Rodriguez DL; Kozel BA; Sparagana S; Roeder ER; McGrew SG; Kurczynski TW; Allison LJ; Amato S; Savage S; Patel A; Stankiewicz P; Beaudet AL; Cheung SW; Lupski JR
    J Med Genet; 2010 May; 47(5):332-41. PubMed ID: 19914906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Connectome Analysis in an Individual with SETD1B -Related Neurodevelopmental Disorder and Epilepsy.
    Weng R; Nenning KH; Schwarz M; Riedhammer KM; Brunet T; Wagner M; Kasprian G; Lehrner J; Zimprich F; Bonelli SB; Krenn M
    J Dev Behav Pediatr; 2022 Aug; 43(6):e419-e422. PubMed ID: 35385430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De novo and inherited TCF20 pathogenic variants are associated with intellectual disability, dysmorphic features, hypotonia, and neurological impairments with similarities to Smith-Magenis syndrome.
    Vetrini F; McKee S; Rosenfeld JA; Suri M; Lewis AM; Nugent KM; Roeder E; Littlejohn RO; Holder S; Zhu W; Alaimo JT; Graham B; Harris JM; Gibson JB; Pastore M; McBride KL; Komara M; Al-Gazali L; Al Shamsi A; Fanning EA; Wierenga KJ; Scott DA; Ben-Neriah Z; Meiner V; Cassuto H; Elpeleg O; Holder JL; Burrage LC; Seaver LH; Van Maldergem L; Mahida S; Soul JS; Marlatt M; Matyakhina L; Vogt J; Gold JA; Park SM; Varghese V; Lampe AK; Kumar A; Lees M; Holder-Espinasse M; McConnell V; Bernhard B; Blair E; Harrison V; ; Muzny DM; Gibbs RA; Elsea SH; Posey JE; Bi W; Lalani S; Xia F; Yang Y; Eng CM; Lupski JR; Liu P
    Genome Med; 2019 Feb; 11(1):12. PubMed ID: 30819258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De novo truncating variants in PHF21A cause intellectual disability and craniofacial anomalies.
    Hamanaka K; Sugawara Y; Shimoji T; Nordtveit TI; Kato M; Nakashima M; Saitsu H; Suzuki T; Yamakawa K; Aukrust I; Houge G; Mitsuhashi S; Takata A; Iwama K; Alkanaq A; Fujita A; Imagawa E; Mizuguchi T; Miyake N; Miyatake S; Matsumoto N
    Eur J Hum Genet; 2019 Mar; 27(3):378-383. PubMed ID: 30487643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel de novo TRIP12 mutation reveals variable phenotypic presentation while emphasizing core features of TRIP12 variations.
    Donoghue T; Garrity L; Ziolkowski A; McPhillips M; Buckman M; Goel H
    Am J Med Genet A; 2020 Jul; 182(7):1801-1806. PubMed ID: 32424948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DYRK1A mutations in two unrelated patients.
    Ruaud L; Mignot C; Guët A; Ohl C; Nava C; Héron D; Keren B; Depienne C; Benoit V; Maystadt I; Lederer D; Amsallem D; Piard J
    Eur J Med Genet; 2015 Mar; 58(3):168-74. PubMed ID: 25641759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De Novo variants in the KMT2A (MLL) gene causing atypical Wiedemann-Steiner syndrome in two unrelated individuals identified by clinical exome sequencing.
    Strom SP; Lozano R; Lee H; Dorrani N; Mann J; O'Lague PF; Mans N; Deignan JL; Vilain E; Nelson SF; Grody WW; Quintero-Rivera F
    BMC Med Genet; 2014 May; 15():49. PubMed ID: 24886118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De Novo and Inherited Pathogenic Variants in KDM3B Cause Intellectual Disability, Short Stature, and Facial Dysmorphism.
    Diets IJ; van der Donk R; Baltrunaite K; Waanders E; Reijnders MRF; Dingemans AJM; Pfundt R; Vulto-van Silfhout AT; Wiel L; Gilissen C; Thevenon J; Perrin L; Afenjar A; Nava C; Keren B; Bartz S; Peri B; Beunders G; Verbeek N; van Gassen K; Thiffault I; Cadieux-Dion M; Huerta-Saenz L; Wagner M; Konstantopoulou V; Vodopiutz J; Griese M; Boel A; Callewaert B; Brunner HG; Kleefstra T; Hoogerbrugge N; de Vries BBA; Hwa V; Dauber A; Hehir-Kwa JY; Kuiper RP; Jongmans MCJ
    Am J Hum Genet; 2019 Apr; 104(4):758-766. PubMed ID: 30929739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deleterious Variation in BRSK2 Associates with a Neurodevelopmental Disorder.
    Hiatt SM; Thompson ML; Prokop JW; Lawlor JMJ; Gray DE; Bebin EM; Rinne T; Kempers M; Pfundt R; van Bon BW; Mignot C; Nava C; Depienne C; Kalsner L; Rauch A; Joset P; Bachmann-Gagescu R; Wentzensen IM; McWalter K; Cooper GM
    Am J Hum Genet; 2019 Apr; 104(4):701-708. PubMed ID: 30879638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.